Catalyst Wire Dossier Catalyst Wire Dossier

Gemfibrozil (Lopid)

Gemfibrozil · Exelan Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Gemfibrozil (Lopid), covering 2009-01-21 to 2024-02-01. Get the full timeline:

Most recent: FDA Approved: GEMFIBROZIL — Supplemental Application (Chartwell RX, LLC)

See pricing